Acute myocardial infarction with spontaneous reperfusion: Clinical characteristics and optimal timing for revascularization

Israel Medical Association Journal

Volumn 9, Issue 4, 2007, Pages 243-246

  Uriel, Nir ^a,b   Moravsky, Gil ^a,b   Blatt, Alex ^a,b   Tourovski, Arkadi ^a,b   Gabara, Ziad ^a,b   Yofik, Inna ^a,b   Danicek, Vladimir ^a,b   Hendler, Alberto ^a,b   Braunstein, Rony ^c   Krakover, Ricardo ^a,b   Vered, Zvi ^a,b   Kaluski, Edo ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Percutaneous coronary intervention reinfarction; Spontaneous coronary reperfusion; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; REPERFUSION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; STROKE; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM;

CORONARY ANGIOGRAPHY; DECISION MAKING; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 34247890058     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rimar D, Crystal E, Battler A, et al. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 2002;88:352-6.
2. Lee CW, Hong MK, Lee JH, et al. Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction. Am J Cardiol 2001;87:951-4; A3.
3. Ishihara M, Inoue I, Kawagoe T, et al. Impact of spontaneous anterograde flow of the infarct artery on left ventricular function in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2002;90:5-9.
4. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001;104:636-41.
5. Taher T, Fu Y, Wagner GS, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 2004;44:38-43.
6. Christian TF, Milavetz JJ, Miller TD, Clements IP, Holmes DR, Gibbons RJ. Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction. Am Heart J 1998;135:421-7.
7. Hackworthy RA, Vogel MB, Harris PJ. Effect of spontaneous reperfusion on myocardial infarct size. Clin Cardiol 1987;10:168-74.
8. Steg PG, Himbert D, Benamer H, et al. Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery. Am Heart J 1997;134(2 Pt 1):248-52.
9. Haider AW, Andreotti F, Hackett DR, et al. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage. J Am Coll Cardiol 1995;26:662-7.
10. Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-8.
11. Brouwer MA, van den Bergh PJ, Aengevaeren WR, et al. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Circulation 2002;106:659-65.
12. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 1999;99:1945-50.
13. Gibson CM. Has my patient achieved adequate myocardial reperfusion? Circulation 2003;108:504-7.